RGEN Q4 2017 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q4 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$42M+62.5% YoY

Gross Profit

$22M54.0% margin

Operating Income

$3M7.8% margin

Net Income

$12M29.3% margin

EPS (Diluted)

$0.27

QoQ Revenue Growth

+13.8%

Cash Flow

Operating Cash Flow

$15M

Free Cash Flow

$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$120M

Total Liabilities

$152M

Stockholders' Equity

$592M

Cash & Equivalents

$174M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$42M	$26M	+62.5%
Gross Profit	$22M	$13M	+67.3%
Operating Income	$3M	$3M	+12.3%
Net Income	$12M	$5M	+142.2%